PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020217
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020217
The global laparoscopy instruments market was valued at USD 17.86 billion in 2025 and is projected to grow to USD 19.40 billion in 2026, reaching USD 41.12 billion by 2034, reflecting a CAGR of 9.84% over the forecast period. North America dominated the market in 2025 with a 50.66% share, driven by the high adoption of minimally invasive surgical techniques and strong presence of key players.
Laparoscopy, commonly known as keyhole surgery, is a minimally invasive surgical approach that allows surgeons to operate inside the abdomen and pelvis through small incisions. The market for laparoscopic devices primarily includes energy devices and endomechanical instruments. Energy devices, such as ultrasonic and high-frequency instruments, assist in cutting tissue efficiently, while endomechanical instruments are used for tissue manipulation, organ removal, and attachment procedures.
Market Growth Drivers
The increasing preference for laparoscopic procedures among both surgeons and patients is one of the major factors driving market growth. Minimally invasive procedures offer numerous benefits, including reduced scarring, shorter recovery times, lower risk of infection, and minimal hospital stays. Additionally, the rising global prevalence of conditions such as gallstones, appendicitis, and hernia has further boosted the demand for laparoscopic instruments.
The COVID-19 pandemic in 2020 caused a temporary decline in demand due to postponed elective surgeries. However, the market rebounded in 2021 and 2022 as surgical volumes increased, leading to a steady upward growth trajectory expected through 2034.
Technological innovations are also propelling market expansion. For instance, the introduction of Hand-assisted Laparoscopic Surgery (HALS) has simplified complex procedures like colectomy, increasing their adoption. Data from the Korean Cancer Association shows that laparoscopic colon cancer surgeries rose from 64.9% in 2013 to 78.5% in 2018, while rectal cancer procedures increased from 65.4% to 81.6% during the same period.
Market Segmentation
By Type: The energy devices segment is the largest, accounting for 29.28% of the market in 2025. Subcategories include generators, vessel sealers, and other electrosurgical tools. Continuous technological advancement and increased focus on capital equipment procurement are driving this segment.
By Usage: Disposable laparoscopic instruments dominate the market, with a 62.47% share in 2025, due to their safety, convenience, and low risk of contamination. They eliminate sterilization challenges and are increasingly preferred over reusable instruments.
By Application: General surgery, including appendectomy, cholecystectomy, hernia repair, and bariatric surgery, accounts for the highest share (47.75% in 2025) and is expected to grow steadily. Rising cases of acute appendicitis and gallstones contribute significantly to this trend. For example, OECD data shows laparoscopic appendectomies in France accounted for 88.4% of total appendectomy procedures in 2020.
By End-user: Hospitals and ambulatory surgical centers dominate with 79.00% market share in 2026, as large patient volumes and widespread trust in hospitals drive instrument adoption.
North America: Valued at USD 9.05 billion in 2025, the region is projected to reach USD 9.8 billion in 2026. Market growth is fueled by increasing surgical procedures, preference for minimally invasive techniques, and strong presence of major companies such as Medtronic, BD, and ETHICON. In the U.S., 90% of cholecystectomies are performed laparoscopically, establishing the method as the gold standard.
Asia Pacific: The region accounted for USD 3.03 billion in 2025, projected to grow to USD 3.32 billion in 2026, due to rising disease prevalence and increasing adoption of laparoscopic surgery over traditional open surgery. Countries like Australia have seen the laparoscopic repair of inguinal hernia rise from 31.7% in 2010 to 46.8% in 2019.
Europe and Japan: Increasing adoption of laparoscopic procedures for colorectal, general, and gynecological surgeries, coupled with strong technological innovation in instruments, supports steady market growth.
Key Market Players
The global market is consolidated with major companies including ETHICON (Johnson & Johnson Services, Inc.), Medtronic, Olympus Corporation, BD, CONMED, Stryker, and others. ETHICON holds the largest share due to its strong portfolio of endomechanical surgical instruments and extensive distribution network. Olympus Corporation has also strengthened its market presence with products like POWERSEAL devices, used in both open and laparoscopic surgeries.
Recent developments include acquisitions and product expansions aimed at enhancing laparoscopic offerings:
Market Challenges
Despite its growth, the market faces restraints, including complications associated with laparoscopic procedures such as lateral thermal spread, surgical smoke hazards, and trocar-related injuries. Additionally, in developing countries, cost considerations lead patients to prefer open surgeries over minimally invasive techniques.
Conclusion
The laparoscopy instruments market is poised for strong growth through 2034, driven by increasing demand for minimally invasive procedures, technological innovations, rising disease burden, and expanding healthcare infrastructure. With a projected market size of USD 41.12 billion by 2034, North America and Asia Pacific are expected to remain key contributors, while the ongoing adoption of energy devices and disposable instruments will continue to shape the market dynamics.
Growth Rate CAGR of 9.84% from 2026-2034
Segmentation By Type
By Usage
By Application
By End-user
By Region